Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States eterinary Vaccines Market Report 2016

  • QYR699511
  • 124 Pages
  • October 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of eterinary Vaccines

Revenue, means the sales value of eterinary Vaccines

This report studies sales (consumption) of eterinary Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

GE Healthcare

Bayer Healthcare

Boehringer Ingelheim

Ceva Animal Health

Elanco Animal Health (Eli Lilly)

Heska Corporation

Merck Animal Healthcare

Merial Inc. (SANOFI)

Virbac

Zoetis

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Companion Animal Vaccines

Livestock Vaccines

Poultry Vaccines

Porcine Vaccines

Equine Vaccines

Aquaculture Vaccines

Other Animal Vaccines

Split by applications, this report focuses on sales, market share and growth rate of eterinary Vaccines in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States eterinary Vaccines Market Report 2016

1 eterinary Vaccines Overview

1.1 Product Overview and Scope of eterinary Vaccines

1.2 Classification of eterinary Vaccines

1.2.1 Companion Animal Vaccines

1.2.2 Livestock Vaccines

1.2.3 Poultry Vaccines

1.2.4 Porcine Vaccines

1.2.5 Equine Vaccines

1.2.6 Aquaculture Vaccines

1.2.7 Other Animal Vaccines

1.3 Application of eterinary Vaccines

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of eterinary Vaccines (2011-2021)

1.4.1 USA eterinary Vaccines Sales and Growth Rate (2011-2021)

1.4.2 USA eterinary Vaccines Revenue and Growth Rate (2011-2021)

2 USA eterinary Vaccines Competition by Manufacturers

2.1 USA eterinary Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA eterinary Vaccines Revenue and Share by Manufactures (2015 and 2016)

2.3 USA eterinary Vaccines Average Price by Manufactures (2015 and 2016)

2.4 eterinary Vaccines Market Competitive Situation and Trends

2.4.1 eterinary Vaccines Market Concentration Rate

2.4.2 eterinary Vaccines Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA eterinary Vaccines Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA eterinary Vaccines Sales and Market Share by Type (2011-2016)

3.2 USA eterinary Vaccines Revenue and Market Share by Type (2011-2016)

3.3 USA eterinary Vaccines Price by Type (2011-2016)

3.4 USA eterinary Vaccines Sales Growth Rate by Type (2011-2016)

4 USA eterinary Vaccines Sales (Volume) by Application (2011-2016)

4.1 USA eterinary Vaccines Sales and Market Share by Application (2011-2016)

4.2 USA eterinary Vaccines Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA eterinary Vaccines Manufacturers Profiles/Analysis

5.1 GE Healthcare

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 eterinary Vaccines Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 GE Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Bayer Healthcare

5.2.2 eterinary Vaccines Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Bayer Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Boehringer Ingelheim

5.3.2 eterinary Vaccines Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Boehringer Ingelheim eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Ceva Animal Health

5.4.2 eterinary Vaccines Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Ceva Animal Health eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Elanco Animal Health (Eli Lilly)

5.5.2 eterinary Vaccines Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Elanco Animal Health (Eli Lilly) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Heska Corporation

5.6.2 eterinary Vaccines Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Heska Corporation eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Merck Animal Healthcare

5.7.2 eterinary Vaccines Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Merck Animal Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Merial Inc. (SANOFI)

5.8.2 eterinary Vaccines Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Merial Inc. (SANOFI) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Virbac

5.9.2 eterinary Vaccines Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Virbac eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Zoetis

5.10.2 eterinary Vaccines Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Zoetis eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

6 eterinary Vaccines Manufacturing Cost Analysis

6.1 eterinary Vaccines Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of eterinary Vaccines

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 eterinary Vaccines Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of eterinary Vaccines Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA eterinary Vaccines Market Forecast (2016-2021)

10.1 USA eterinary Vaccines Sales, Revenue Forecast (2016-2021)

10.2 USA eterinary Vaccines Sales Forecast by Type (2016-2021)

10.3 USA eterinary Vaccines Sales Forecast by Application (2016-2021)

10.4 eterinary Vaccines Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of eterinary Vaccines

Table Classification of eterinary Vaccines

Figure USA Sales Market Share of eterinary Vaccines by Type in 2015

Figure Companion Animal Vaccines Picture

Figure Livestock Vaccines Picture

Figure Poultry Vaccines Picture

Figure Porcine Vaccines Picture

Figure Equine Vaccines Picture

Figure Aquaculture Vaccines Picture

Figure Other Animal Vaccines Picture

Table Application of eterinary Vaccines

Figure USA Sales Market Share of eterinary Vaccines by Application in 2015

Figure USA eterinary Vaccines Sales and Growth Rate (2011-2021)

Figure USA eterinary Vaccines Revenue and Growth Rate (2011-2021)

Table USA eterinary Vaccines Sales of Key Manufacturers (2015 and 2016)

Table USA eterinary Vaccines Sales Share by Manufacturers (2015 and 2016)

Figure 2015 eterinary Vaccines Sales Share by Manufacturers

Figure 2016 eterinary Vaccines Sales Share by Manufacturers

Table USA eterinary Vaccines Revenue by Manufacturers (2015 and 2016)

Table USA eterinary Vaccines Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA eterinary Vaccines Revenue Share by Manufacturers

Table 2016 USA eterinary Vaccines Revenue Share by Manufacturers

Table USA Market eterinary Vaccines Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market eterinary Vaccines Average Price of Key Manufacturers in 2015

Figure eterinary Vaccines Market Share of Top 3 Manufacturers

Figure eterinary Vaccines Market Share of Top 5 Manufacturers

Table USA eterinary Vaccines Sales by Type (2011-2016)

Table USA eterinary Vaccines Sales Share by Type (2011-2016)

Figure USA eterinary Vaccines Sales Market Share by Type in 2015

Table USA eterinary Vaccines Revenue and Market Share by Type (2011-2016)

Table USA eterinary Vaccines Revenue Share by Type (2011-2016)

Figure Revenue Market Share of eterinary Vaccines by Type (2011-2016)

Table USA eterinary Vaccines Price by Type (2011-2016)

Figure USA eterinary Vaccines Sales Growth Rate by Type (2011-2016)

Table USA eterinary Vaccines Sales by Application (2011-2016)

Table USA eterinary Vaccines Sales Market Share by Application (2011-2016)

Figure USA eterinary Vaccines Sales Market Share by Application in 2015

Table USA eterinary Vaccines Sales Growth Rate by Application (2011-2016)

Figure USA eterinary Vaccines Sales Growth Rate by Application (2011-2016)

Table GE Healthcare Basic Information List

Table GE Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure GE Healthcare eterinary Vaccines Sales Market Share (2011-2016)

Table Bayer Healthcare Basic Information List

Table Bayer Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer Healthcare eterinary Vaccines Sales Market Share (2011-2016)

Table Boehringer Ingelheim Basic Information List

Table Boehringer Ingelheim eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Boehringer Ingelheim eterinary Vaccines Sales Market Share (2011-2016)

Table Ceva Animal Health Basic Information List

Table Ceva Animal Health eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ceva Animal Health eterinary Vaccines Sales Market Share (2011-2016)

Table Elanco Animal Health (Eli Lilly) Basic Information List

Table Elanco Animal Health (Eli Lilly) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Elanco Animal Health (Eli Lilly) eterinary Vaccines Sales Market Share (2011-2016)

Table Heska Corporation Basic Information List

Table Heska Corporation eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Heska Corporation eterinary Vaccines Sales Market Share (2011-2016)

Table Merck Animal Healthcare Basic Information List

Table Merck Animal Healthcare eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Animal Healthcare eterinary Vaccines Sales Market Share (2011-2016)

Table Merial Inc. (SANOFI) Basic Information List

Table Merial Inc. (SANOFI) eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merial Inc. (SANOFI) eterinary Vaccines Sales Market Share (2011-2016)

Table Virbac Basic Information List

Table Virbac eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Virbac eterinary Vaccines Sales Market Share (2011-2016)

Table Zoetis Basic Information List

Table Zoetis eterinary Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Zoetis eterinary Vaccines Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of eterinary Vaccines

Figure Manufacturing Process Analysis of eterinary Vaccines

Figure eterinary Vaccines Industrial Chain Analysis

Table Raw Materials Sources of eterinary Vaccines Major Manufacturers in 2015

Table Major Buyers of eterinary Vaccines

Table Distributors/Traders List

Figure USA eterinary Vaccines Production and Growth Rate Forecast (2016-2021)

Figure USA eterinary Vaccines Revenue and Growth Rate Forecast (2016-2021)

Table USA eterinary Vaccines Production Forecast by Type (2016-2021)

Table USA eterinary Vaccines Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370